CVSCVS Health
$86.18+19% 1Y
$86.18
$69.4752 weeks$110.58
Latest close: back above its 200-day averageOct 9, 2026what changed →
CVS in its own filings
Nothing in CVS's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
635
Events found in the filings · across 2,968 filings · the record starts in 1994
- Hard flags
- none
Hard flags
- Most recent filing
- Aug 17, 2026
Most recent filing · Form 8-K
- Record starts
- Mar 14, 1994
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Oct 28, 2026
- Change in certifying accountanthistorical
- 2007-10-01
- Material impairmenthistorical
- 2021-11-18
- SEC comment-letter activity65 occurrences
- 2024-11-21
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 17, 2026On August 13, 2026, Larry M. Robbins notified the Board of Directors (the “Board”) of CVS Health Corporation (the “Company”) of his resignation from the Board, effective immediately.Director or officer change · Form 8-K
- Aug 5, 2026Second quarter total revenues increased to $106.1 billion, up 7.3% year-over-year.Earnings release · press release
- May 18, 2026On May 14, 2026, CVS Health Corporation (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”)Director or officer change · Form 8-K
- May 6, 2026First quarter total revenues increased to $100.4 billion, up 6.2% year-over-year.Earnings release · press release
- Mar 19, 2026: On March 18, 2026, the Board of Directors (the “Board”) of CVS Health Corporation (“CVS Health” or the “Company”) elected John E. Gallina to serve on the Board, effective March 19, 2026.Director or officer change · Form 8-K
- Feb 10, 2026Fourth Quarter Highlights.Earnings release · press release
- Nov 20, 2025Appointment of J. David Joyner as Chair of the Board of Directors On November 20, 2025, the Board of Directors (the “Board”) of CVS Health Corporation (the “Company”) appointed J. David Joyner, President and Chief Executive Officer of the Company, to the additional role of Chair of the Board, effective January 1, 2026.Other event · Form 8-K
- Sep 22, 2025On September 22, 2025, Omnicare, LLC (“Omnicare”), a wholly owned indirect subsidiary of CVS Health Corporation (NYSE: CVS), issued a press release announcing that Omnicare and certain of its subsidiary entities (the “Omnicare Entities”) have voluntarily initiated chapter 11 proceedings under the U.S. Bankruptcy Code …Other event · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…